|Other Names||Fetal and adult testis-expressed transcript protein, Cancer/testis antigen 43, CT43, Tumor antigen BJ-HCC-2, FATE1, FATE|
|Target/Specificity||The synthetic peptide sequence is selected from aa 107-120 of HUMAN FATE1|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Membrane; Single-pass membrane protein|
|Tissue Location||Testis-specific in fetus (aged from 6 to 11 weeks). In adult, expressed predominantly in testis, with some expression in lung, heart, kidney, adrenal gland and whole brain EMBL; AF249872; AAK69024.1; -; mRNA EMBL; AY101182; AAM48744.1; -; mRNA EMBL; AK057369; BAB71454.1; -; mRNA EMBL; BC022064; AAH22064.1; -; mRNA CCDS; CCDS14700.1; - RefSeq; NP_149076.1; NM_033085.2 UniGene; Hs.301960; - ProteinModelPortal; Q969F0; - SMR; Q969F0; - BioGrid; 124636; 54 IntAct; Q969F0; 90 MINT; MINT-1474102; - STRING; 9606.ENSP00000359375; - BioMuta; FATE1; - DMDM; 37078481; - PaxDb; Q969F0; - PeptideAtlas; Q969F0; - PRIDE; Q969F0; - DNASU; 89885; - Ensembl; ENST00000370350; ENSP00000359375; ENSG00000147378 GeneID; 89885; - KEGG; hsa:89885; - UCSC; uc004fex.4; human CTD; 89885; - DisGeNET; 89885; - GeneCards; FATE1; - HGNC; HGNC:24683; FATE1 HPA; HPA034604; - MIM; 300450; gene neXtProt; NX_Q969F0; - OpenTargets; ENSG00000147378; - PharmGKB; PA134875203; - eggNOG; ENOG410J190; Eukaryota eggNOG; ENOG410YXUY; LUCA GeneTree; ENSGT00390000006832; - HOGENOM; HOG000293282; - HOVERGEN; HBG051556; - InParanoid; Q969F0; - OMA; WNMTATR; - OrthoDB; EOG091G0QVT; - PhylomeDB; Q969F0; - TreeFam; TF338514; - BioCyc; ZFISH:ENSG00000147378-MONOMER; - ChiTaRS; FATE1; human GeneWiki; FATE1; - GenomeRNAi; 89885; - PRO; PR:Q969F0; - Proteomes; UP000005640; Chromosome X Bgee; ENSG00000147378; - CleanEx; HS_FATE1; - ExpressionAtlas; Q969F0; baseline and differential Genevisible; Q969F0; HS GO; GO:0005783; C:endoplasmic reticulum; IDA:LIFEdb GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW InterPro; IPR008518; FATE/Miff/Tango-11 Pfam; PF05644; Miff; 1 1: Evidence at protein level; Complete proteome; Membrane; Polymorphism; Reference proteome; Transmembrane; Transmembrane helix CHAIN 1 183 Fetal and adult testis-expressed transcript protein /FTId=PRO_0000087200 TRANSMEM 163 181 Helical. VARIANT 10 10 A -> V (common polymorphism; 16% of the population; infertile and fertile individuals; dbSNP:rs3810715) /FTId=VAR_016917 VARIANT 34 34 I -> T (in fertile and infertile individuals) /FTId=VAR_016918 VARIANT 125 125 S -> R (in fertile and infertile individuals; dbSNP:rs141497002) /FTId=VAR_016919 SEQUENCE 183 AA; 20712 MW; F3448EDCBCD148CB CRC64; MAGGPPNTKA EMEMSLAEEL NHGRQGENQE HLVIAEMMEL GSRSRGASQK KQKLEQKAAG SASAKRVWNM TATRPKKMGS QLPKPRMLRE SGHGDAHLQE YAGNFQGIRF HYDRNPGTDA VAQTSLEEFN VLEMEVMRRQ LYAVNRRLRA LEEQGATWRH RETLIIAVLV SASIANLWLW MNQ|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Olesen C.,et al.Mol. Cell. Endocrinol. 184:25-32(2001).
Dong X.-Y.,et al.Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Olesen C.,et al.Hum. Genet. 113:195-201(2003).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.